PX-130

N/A

Report date: 2024/06/14 16:12:50

Base Information

Drug NamePX-130
Drug Alias NamePX-130PX130
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionInterleukin-13 inhibitorsInterleukin-22 inhibitors
TargetsInterleukin-13Interleukin-22
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProteologix Inc
China Registration ClassN/A

Develop Information

Active CompaniesProteologix IncJohnson & Johnson
Inactive CompaniesN/A
Active IndicationsDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A